SMTL ID : 2bxk.1

Human serum albumin complexed with myristate, azapropazone and indomethacin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

6 x MYR: MYRISTIC ACID(Non-covalent)

MYR.1: 10 residues within 4Å: Chain A: L.115, R.117, M.123, F.134, L.135, Y.138, I.142, Y.161, F.165, R.186 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:R.117, A:F.134, A:L.135, A:Y.138, A:Y.138, A:I.142, A:Y.161, A:Y.161, A:Y.161, A:F.165 Salt bridges: A:R.117, A:R.186 MYR.2: 9 residues within 4Å: Chain A: R.10, F.19, Y.150, L.251, A.254, R.257, A.258, L.283, S.287 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.19, A:A.258, A:L.283 Hydrogen bonds: A:Y.150, A:S.287, A:S.287 Salt bridges: A:R.257 MYR.3: 7 residues within 4Å: Chain A: S.342, V.344, R.348, I.388, N.391, L.453, R.485 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.388 Hydrogen bonds: A:S.342 Salt bridges: A:R.348, A:R.485 MYR.4: 9 residues within 4Å: Chain A: L.387, R.410, Y.411, L.423, L.430, L.460, R.485, F.488, S.489 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.411, A:Y.411, A:L.423, A:L.430, A:L.460, A:F.488, A:F.488 Hydrogen bonds: A:Y.411, A:Y.411 Water bridges: A:K.414 Salt bridges: A:R.410, A:K.414 MYR.5: 11 residues within 4Å: Chain A: Y.401, N.405, F.502, F.507, K.525, L.532, M.548, F.551, A.552, S.579, Q.580 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.502, A:F.507, A:F.507, A:K.525, A:L.532, A:M.548, A:F.551, A:F.551, A:Q.580 Hydrogen bonds: A:M.548 Salt bridges: A:K.525 MYR.6: 7 residues within 4Å: Chain A: R.209, A.210, A.213, D.324, L.327, G.328, S.480 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.210, A:A.213, A:L.327 Hydrogen bonds: A:S.480

1 x IMN: INDOMETHACIN(Non-covalent)

IMN.7: 12 residues within 4Å: Chain A: K.199, S.202, L.203, G.207, A.210, F.211, W.214, A.215, R.218, L.238, D.451 Ligands: AZQ.8 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.211, A:F.211, A:W.214, A:W.214 Hydrogen bonds: A:D.451 Salt bridges: A:R.218 pi-Stacking: A:W.214 pi-Cation interactions: A:H.242

1 x AZQ: AZAPROPAZONE(Non-covalent)

AZQ.8: 12 residues within 4Å: Chain A: K.199, R.218, L.219, R.222, F.223, L.238, H.242, R.257, I.264, I.290, A.291 Ligands: IMN.7 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:R.218 Hydrogen bonds: A:K.199

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ghuman, J. et al., Structural Basis of the Drug-Binding Specificity of Human Serum Albumin. J.Mol.Biol. (2005)

Release Date

2005-09-22

Peptides

SERUM ALBUMIN: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

SERUM ALBUMIN

Related Entries With Identical Sequence